Hangzhou Alltest Biotech Co., Ltd.

Rachunek Zysków i Strat


index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Rok finansowy 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 62 68 419 123 525 288 347 361 877 2,099 625 287 379 236 152 172 195 200 197 222 252 208
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 744.2% 325.6% -17.18% 193.5% 66.9% 628.2% 79.8% -20.69% -56.82% -88.75% -75.71% -39.94% -48.55% -15.34% 29.6% 28.7% 29.3% 4.3%
Marża brutto 63.7% 72.9% 88.5% 78.0% 79.5% 71.3% 71.5% 60.3% 41.3% 67.9% 59.1% 46.9% 27.1% 52.7% 37.1% 50.9% 51.3% 50.1% 60.0% 57.1% 56.2% 55.6%
Koszty i Wydatki (mln) 44 32 78 48 152 116 136 203 550 782 368 283 323 184 144 144 115 148 126 137 130 144
EBIT (mln) 18 37 330 73 352 174 206 180 336 1,242 295 31 -205 46 45 38 79 47 95 85 124 65
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 1890.7% 366.2% -37.71% 148.1% -4.53% 612.5% 43.1% -83.08% -160.87% -96.28% -84.78% 24.6% 138.8% 2.3% 111.3% 122.8% 56.5% 36.4%
EBIT (%) 28.4% 55.2% 78.8% 59.1% 67.0% 60.5% 59.3% 49.9% 38.4% 59.2% 47.2% 10.7% -54.06% 19.6% 29.5% 22.1% 40.8% 23.7% 48.2% 38.3% 49.4% 31.0%
Przychody fiansowe (mln) 0 -0 1 0 0 -0 15 -33 56 -4 20 -48 75 -8 30 -51 75 -5 22 1 0 2
Koszty finansowe (mln) 2 1 -1 6 14 -2 12 -2 25 1 0 1 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 1 1 1 1 1 3 3 6 6 15 15 18 18 13 13 12 12 5 -16 -0 0 0
EBITDA (mln) 17 36 352 75 384 177 222 144 351 1,313 296 31 52 63 12 50 41 61 78 84 124 65
EBITDA(%) 27.7% 53.6% 83.9% 61.1% 73.2% 61.3% 63.9% 40.0% 40.0% 62.6% 47.3% 10.9% 13.8% 26.5% 8.0% 29.0% 20.9% 30.4% 39.8% 38.0% 49.4% 31.0%
NOPLAT (mln) 18 36 330 73 352 174 205 180 336 1,237 291 62 -208 46 31 38 79 47 92 84 125 65
Podatek (mln) 2 4 48 10 51 24 29 24 53 188 37 4 -32 6 1 7 3 3 13 10 19 3
Zysk Netto (mln) 16 32 283 63 302 150 176 156 283 1,049 254 58 -176 41 31 30 79 45 79 74 105 61
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 1802.1% 368.5% -37.83% 148.8% -6.04% 598.2% 44.2% -62.98% -162.01% -96.14% -87.91% -47.47% 145.0% 10.5% 158.0% 142.4% 32.8% 36.7%
Zysk netto (%) 25.5% 47.4% 67.4% 51.0% 57.4% 52.1% 50.6% 43.2% 32.3% 50.0% 40.6% 20.2% -46.42% 17.2% 20.2% 17.7% 40.6% 22.4% 40.2% 33.2% 41.7% 29.4%
EPS 0.39 0.53 6.97 1.55 7.43 2.51 4.33 3.85 6.98 25.84 6.24 1.42 -2.25 0.52 0.39 0.39 0.97 0.56 0.99 0.95 1.28 0.77
EPS (rozwodnione) 0.39 0.53 6.97 1.55 7.43 2.51 4.33 3.85 6.98 25.84 6.24 1.42 -2.25 0.52 0.39 0.39 0.99 0.56 0.99 0.95 1.28 0.77
Ilośc akcji (mln) 41 60 41 41 41 60 41 41 41 41 41 41 78 78 78 78 79 80 80 78 83 80
Ważona ilośc akcji (mln) 41 41 41 41 41 41 41 41 41 41 41 41 78 78 78 78 79 80 80 78 83 80
Waluta CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY